Marc Lenjou

2.4k total citations
41 papers, 2.0k citations indexed

About

Marc Lenjou is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Marc Lenjou has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 14 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Marc Lenjou's work include Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Marc Lenjou is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Marc Lenjou collaborates with scholars based in Belgium, Czechia and United States. Marc Lenjou's co-authors include Dirk R. Van Bockstaele, Griet Nijs, Zwi Berneman, Filip Lardon, Viggo Van Tendeloo, Peter Ponsaerts, Dirk Van Bockstaele, Christine Van Broeckhoven, Harry Van Onckelen and Dirk Inzé and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Marc Lenjou

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Lenjou Belgium 26 1.0k 861 430 275 209 41 2.0k
Paul Waring Australia 26 1.2k 1.1× 799 0.9× 894 2.1× 190 0.7× 110 0.5× 65 3.1k
Ichiro Kawashima Japan 24 831 0.8× 853 1.0× 458 1.1× 102 0.4× 209 1.0× 73 1.8k
Mark Egerton Australia 19 1.3k 1.2× 732 0.9× 428 1.0× 105 0.4× 166 0.8× 23 2.2k
Paul F. Schendel United States 23 1.8k 1.7× 465 0.5× 401 0.9× 582 2.1× 285 1.4× 34 2.8k
Sharlotte Kovacic United States 7 846 0.8× 610 0.7× 260 0.6× 260 0.9× 301 1.4× 7 1.8k
Ian A. MacNeil United States 13 1.1k 1.1× 443 0.5× 183 0.4× 126 0.5× 161 0.8× 25 2.0k
Mepur H. Ravindranath United States 26 1.0k 1.0× 1.2k 1.4× 372 0.9× 96 0.3× 76 0.4× 116 2.3k
Jianxin Fu China 23 1.3k 1.3× 753 0.9× 794 1.8× 172 0.6× 270 1.3× 68 2.5k
Benjamin Peeters Belgium 21 1.3k 1.2× 486 0.6× 188 0.4× 378 1.4× 49 0.2× 49 2.1k
Karyl I. Minard United States 17 1.1k 1.1× 845 1.0× 170 0.4× 247 0.9× 55 0.3× 26 2.0k

Countries citing papers authored by Marc Lenjou

Since Specialization
Citations

This map shows the geographic impact of Marc Lenjou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lenjou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lenjou more than expected).

Fields of papers citing papers by Marc Lenjou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Lenjou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lenjou. The network helps show where Marc Lenjou may publish in the future.

Co-authorship network of co-authors of Marc Lenjou

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Lenjou. A scholar is included among the top collaborators of Marc Lenjou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Lenjou. Marc Lenjou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cools, Nathalie, Viggo Van Tendeloo, Evelien Smits, et al.. (2007). Immunosuppression induced by immature dendritic cells is mediated by TGF‐β/IL‐10 double‐positive CD4+ regulatory T cells. Journal of Cellular and Molecular Medicine. 12(2). 690–700. 66 indexed citations
2.
Smits, Evelien, Peter Ponsaerts, Ann Van Driessche, et al.. (2007). Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells. Leukemia. 21(8). 1691–1699. 37 indexed citations
3.
Gulck, Ellen Van, Peter Ponsaerts, Griet Nijs, et al.. (2006). Simultaneous Activation of Viral Antigen-specific Memory CD4+ and CD8+ T-cells Using mRNA-electroporated CD40-activated Autologous B-cells. Journal of Immunotherapy. 29(5). 512–523. 10 indexed citations
4.
Fordel, Elke, Liesbet Thijs, Wim Martinet, et al.. (2006). Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neuroscience Letters. 410(2). 146–151. 139 indexed citations
5.
Vanparys, Caroline, Marleen Maras, Marc Lenjou, et al.. (2006). Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells. Toxicology in Vitro. 20(7). 1238–1248. 60 indexed citations
6.
Smits, Evelien, Peter Ponsaerts, Marc Lenjou, et al.. (2004). RNA-based gene transfer for adult stem cells and T cells. Leukemia. 18(11). 1898–1902. 56 indexed citations
7.
Pauwels, Bea, A.E.C. Korst, G Pattyn, et al.. (2003). Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. International Journal of Radiation Oncology*Biology*Physics. 57(4). 1075–1083. 63 indexed citations
8.
Świątek, Agnieszka, Marc Lenjou, Dirk Van Bockstaele, Dirk Inzé, & Harry Van Onckelen. (2002). Differential Effect of Jasmonic Acid and Abscisic Acid on Cell Cycle Progression in Tobacco BY-2 Cells. PLANT PHYSIOLOGY. 128(1). 201–211. 158 indexed citations
9.
Vermeulen, Katrien, Miroslav Strnad, Vladimı́r Kryštof, et al.. (2002). Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases. Leukemia. 16(3). 299–305. 47 indexed citations
10.
Ponsaerts, Peter, Viggo Van Tendeloo, Nathalie Cools, et al.. (2002). mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia. 16(7). 1324–1330. 46 indexed citations
11.
Willems, Roel, Herman Slegers, Inez Rodrigus, et al.. (2002). Extracellular nucleoside diphosphate kinase NM23/NDPK modulates normal hematopoietic differentiation. Experimental Hematology. 30(7). 640–648. 16 indexed citations
12.
Lenjou, Marc, et al.. (2001). Epidemiology: Culture of bovine bone marrow progenitor cells in vitro. Veterinary Quarterly. 23(4). 170–175. 7 indexed citations
14.
Tendeloo, Viggo Van, Roel Willems, Peter Ponsaerts, et al.. (2000). High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery. Gene Therapy. 7(16). 1431–1437. 51 indexed citations
15.
Lenjou, Marc, et al.. (1999). A low content in zeatin type cytokinins is not restrictive for the occurrence of G1/S transition in tobacco BY‐2 cells. FEBS Letters. 460(1). 123–128. 29 indexed citations
16.
Hoeben, Dagmar, Christian Burvenich, Marc Lenjou, et al.. (1999). In vitro effect of ketone bodies, glucocorticosteroids and bovine pregnancy-associated glycoprotein on cultures of bone marrow progenitor cells of cows and calves. Veterinary Immunology and Immunopathology. 68(2-4). 229–240. 47 indexed citations
19.
Snoeck, Hans‐Willem, Adriaan C. Moulijn, Filip Lardon, et al.. (1996). Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.. The Journal of Experimental Medicine. 183(2). 705–710. 50 indexed citations
20.
Snoeck, Hans‐Willem, Dirk R. Van Bockstaele, Marc Lenjou, et al.. (1994). Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells.. The Journal of Experimental Medicine. 180(3). 1177–1182. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026